DELIVERY ORDER

Active

UNIVERSITY OF OKLAHOMA

75N91026F00001

Department of Health and Human Services › National Institutes of Health › NIH NCI

$1.1M

obligated · signed 2 months ago

TRIPLE NEGATIVE BREAST CANCER VACCINES

USAspending.govSolicitation TORFP 2026 E-03Under 75N91024D00005IDC

Obligated: $1,147,754
Ceiling (all options): $1,147,754; 100% obligated
Signed: Sep 10, 2026
Awarding agency: National Institutes of Health
Performance start: Sep 14, 2026
Current end: Sep 13, 2028
Potential end: Sep 13, 2028; with all options
Pricing: FIRM FIXED PRICE

Competition: FULL AND OPEN COMPETITION
Offers received: 1
Set-aside: —
Solicitation procedure: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Program: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT

Performance timeline

Start

Sep 14, 2026

End

Sep 13, 2028

with all options

Loading status

Elapsed

Recompete outlook

11months until recompete window

Estimated start: Sep 13, 2027

Recipient

UNIVERSITY OF OKLAHOMA

Contract 75N91026F00001

UEI

GY8NMUZQXVS7

Parent Company

UNIVERSITY OF OKLAHOMA

Capabilities & Certifications

Category BusinessEducational InstitutionGovernmentHigher EducationU.S. National GovernmentNot Designated A Small BusinessHigher Education (Public)U.S. Regional/State Government

Headquarters Location

865 RESEARCH PKWY, OKLAHOMA CITY, OK, 73104

Congressional District: 05

Contract value

Current Obligation

$1,147,754

Base + Exercised Options

$1,147,754

Total Ceiling Value

$1,147,754

Contract value consumed$1.1M of $1.1M (100%)

Over 75% of contract value has been obligated. Options or modifications may be needed soon.

Contract Type

FIRM FIXED PRICE

Multi-Year Contract

Modifications & obligations

Scope & classification

NAICS

541714

RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

54├Professional, Scientific, and Technical Services

5417├Scientific Research and Development Services

541714└Research and Development in Biotechnology (except Nanobiotechnology)

PSC

AN12

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

A├RESEARCH AND DEVELOPMENT

AN├N – Health R&D Services

AN12└HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Place of Performance

OKLAHOMA CITY, OK, 73104

Congressional District: 05

Awarding & funding agencies

Awarding Agency

Department of Health and Human Services

Top-tier agency

National Institutes of Health

Sub-tier agency

NIH NCI

Office

Funding Agency

Department of Health and Human Services

Top-tier agency

National Institutes of Health

Sub-tier agency

NIH NCI

Office

Contract Vehicle

75N91024D00005

IDC

Department of Health and Human Services

Award type: MULTIPLE AWARD

Additional contract details

Solicitation procedures, competition exceptions, labor standards and account totals.